Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial
Open Access
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 282, 1011-1020
Abstract
No abstract availableKeywords
Funding Information
- Shionogi
- Mitsubishi Tanabe Pharma Corporation
- Mochida Pharmaceutical Company
This publication has 37 references indexed in Scilit:
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- The first 100 patients in the SUN(^_^)D trial (strategic use of new generation antidepressants for depression): examination of feasibility and adherence during the pilot phaseTrials, 2012
- Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitorsCurrent Medical Research and Opinion, 2011
- Persistence and compliance to antidepressant treatment in patients with depression: A chart reviewBMC Psychiatry, 2009
- A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorderCurrent Medical Research and Opinion, 2007
- Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority studyCurrent Medical Research and Opinion, 2007
- Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side EffectsJournal of Psychiatric Practice, 2006
- Reliability and validity of Japanese version of the Mini‐International Neuropsychiatric InterviewPsychiatry and Clinical Neurosciences, 2005
- EscitalopramExpert Opinion on Investigational Drugs, 2002
- Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal ReceptorsNeuropsychopharmacology, 2001